FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1217324004: Levamlodipine besilate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Apr 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5035638014 (S)-amlodipine besilate en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
5035639018 Levamlodipine besilate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5035640016 S-amlodipine besylate en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
5035641017 Levamlodipine besilate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5035642012 Levamlodipine besylate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Levamlodipine besilate (substance) Is a Hypotensive agent (substance) true Inferred relationship Some
Levamlodipine besilate (substance) Is a Dihydropyridine derivative calcium channel blocker true Inferred relationship Some
Levamlodipine besilate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Calcium channel blocker (disposition) true Inferred relationship Some
Levamlodipine besilate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Levamlodipine (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely levamlodipine (as levamlodipine besilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Levamlodipine besilate (substance) Inferred relationship Some 1
Product containing precisely levamlodipine (as levamlodipine besilate) 5 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Levamlodipine besilate (substance) Inferred relationship Some 1
Product containing precisely atenolol 50 milligram and levamlodipine (as levamlodipine besilate) 5 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Levamlodipine besilate (substance) Inferred relationship Some 1
Product containing precisely atenolol 50 milligram and levamlodipine (as levamlodipine besilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Levamlodipine besilate (substance) Inferred relationship Some 1
Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Levamlodipine besilate (substance) Inferred relationship Some 1
Product containing precisely levamlodipine (as levamlodipine besilate) 2.5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Levamlodipine besilate (substance) Inferred relationship Some 1
Product containing precisely levamlodipine (as levamlodipine besilate) 5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Levamlodipine besilate (substance) Inferred relationship Some 1

Reference Sets

GB English

US English

Back to Start